Position in PFE
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$3,178,294
-$138,150 QoQ
Shares Held
131,989
+11.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#778
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Avengers, Inc. holds $17,063,900 across 8 Drug Manufacturers - General names. PFE ranks #2 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,625 | $12,095,321 | |
| 2 | PFE |
Pfizer Inc
This page
|
131,989 | $3,178,294 | |
| 3 | LLY |
ELI LILLY & Co
|
1,313 | $1,574,851 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,344 | $169,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
132 | $16,962 | |
| 6 | ABBV |
AbbVie Inc.
|
50 | $12,582 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
141 | $8,124 | |
| 8 | AMGN |
Amgen Inc
|
22 | $7,966 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,178,294 | 131,989 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $3,316,444 | 118,107 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $2,736,435 | 109,897 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $2,504,480 | 98,292 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,176,558 | 89,792 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,907,291 | 75,268 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,395,053 | 52,584 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $808,641 | 27,942 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $514,104 | 18,374 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $335,497 | 12,090 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $197,096 | 6,846 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $224,229 | 6,760 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $241,281 | 6,578 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $265,812 | 6,515 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $330,754 | 6,455 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $280,370 | 6,407 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $336,023 | 6,409 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $329,257 | 6,360 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $431,655 | 7,310 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $306,833 | 7,134 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $278,075 | 7,101 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $254,986 | 7,038 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $254,982 | 6,927 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||